Abstract
In a population based series of 4070 children with acute lymphoblastic leukaemia treated in Britain during 1971-82, the five year survival rate improved from 37% for those treated in 1971-3 to 66% in 1980-2. During the same period there was an increase in the proportion of children included in the Medical Research Council trials and an increase in the proportion who were treated at centres with an average of at least six new patients per year. Survival rates were significantly higher for children who were included in the trials than for those who were not. Among children not in the trials, the survival rate was highest at centres treating at least six children per year and lowest at those with fewer than one per year. The increase in the numbers of children treated according to standardised protocols, particularly within controlled clinical trials, has had a major impact on the mortality from childhood acute lymphoblastic leukaemia.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chessells J. M., Hardisty R. M., Richards S. Long survival in childhood lymphoblastic leukaemia. Br J Cancer. 1987 Mar;55(3):315–319. doi: 10.1038/bjc.1987.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chessells J. M., Leiper A. D., Tiedemann K., Hardisty R. M., Richards S. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia. Arch Dis Child. 1987 Feb;62(2):172–176. doi: 10.1136/adc.62.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eden O. B., Stiller C. A., Gerrard M. P. Improved survival for childhood acute lymphoblastic leukemia: possible effect of protocol compliance. Pediatr Hematol Oncol. 1988;5(2):83–91. doi: 10.3109/08880018809031258. [DOI] [PubMed] [Google Scholar]
- George S. L., Aur R. J., Mauer A. M., Simone J. V. A reappraisal of the results of stopping therapy in childhood leukemia. N Engl J Med. 1979 Feb 8;300(6):269–273. doi: 10.1056/NEJM197902083000601. [DOI] [PubMed] [Google Scholar]
- Mandelli F., Amadori S., Ceci A., Guazzelli C., Madon E., Marchi A., Masera G., Paolucci G., Zanesco L. Long-term survival in childhood acute lymphocytic leukemia in Italy. Cancer. 1981 Dec 1;48(11):2364–2367. doi: 10.1002/1097-0142(19811201)48:11<2364::aid-cncr2820481104>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- Meadows A. T., Kramer S., Hopson R., Lustbader E., Jarrett P., Evans A. E. Survival in childhood acute lymphocytic leukemia: effect of protocol and place of treatment. Cancer Invest. 1983;1(1):49–55. doi: 10.3109/07357908309040932. [DOI] [PubMed] [Google Scholar]
- Mott M. G., Chessells J. M., Willoughby M. L., Mann J. R., Morris-Jones P. H., Malpas J. S., Palmer M. K. Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG). Br J Cancer. 1984 Oct;50(4):457–462. doi: 10.1038/bjc.1984.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]